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a b s t r a c t
Background: The use of Y-shaped aorto-coronary saphenous vein grafts is most commonly
driven by efforts to replace the poor quality (length) of the vein grafts or to minimise
manipulation of the atheromatous ascending aorta (Jarvis [1]). We found only a few case
reports describing PCI of bifurcation lesions in vein grafts in the available scientiﬁc literature
(Karalis [2], Prosser and Bailey [3], Chan et al. [4]).
Method: We present two case reports of patients with bifurcation lesions in Y saphenous
vein grafts. In case No. 1, implantation of a dedicated bifurcation stent Tryton (4.0/
3.518 mm) and DES Promus Element (4.020 mm) was used to treat the Y-graft bifurcation
lesion. In case No. 2, due to satisfying result of side branch stenosis predilation, the
bifurcation lesion was treated by a drug-eluting balloon catheter SeQuent Please
(4.015 mm) and only a short stent (Liberte 4.08 mm) was implanted in the proximal
residual stenosis of the main branch.
Results: In both cases satisfying periprocedural angiographic results with ﬁnal TIMI ﬂow 3
were achieved. During the 12-month follow-up no MACE (CV death, AMI, TVR) has been
recorded and both patients were without residual angina pectoris. Persistent satisfying
angiographic results were conﬁrmed on MS-CT coronarography.
Conclusion: PCI of the bifurcation lesions in the vein grafts is a rare but complicated
condition. In our two case reports we demonstrated that the use of a dedicated bifurcation
Tryton Side Branch Stent, as well as the SeQuent Please paclitaxel coated balloon catheter for
PCI of the bifurcation lesions in Y vein grafts, is technically feasible with satisfactory long-
term results.
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Introduction
The use of Y-shaped aorto-coronary saphenous vein grafts is
most commonly driven by efforts to replace the poor quality
(length) of the vein grafts or to minimise manipulation of the
atheromatous ascending aorta [1]. We found only a few case
reports describing PCI of bifurcation lesions in vein grafts in
the available scientiﬁc literature [2–4].
We present two case reports of patients with bifurcation
lesions in Y-shaped vein grafts.
Case report 1
A 67-year-old male underwent CABG surgery in 2008 (LIMA to
LAD, Y saphenous vein graft to Diagonal and LCx; SVG central
anastomosis to the Diagonal was grafted ‘‘end-to-side’’ to the
Fig. 2 – Process of Tryton stent implantation into the side
branch SVD to Diagonal.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 8 2 – e 3 8 7 e383SVG to LCx), followed by PCI of the middle third of the SVG to
the LCx and drug eluting stent implantation (Cypher
3.518 mm) in 2010. Echocardiography revealed mildly re-
duced left ventricular systolic function, i.e. LVEF was 45%. The
patient suffered from hypertension and hyperlipoproteinae-
mia.
This patient was admitted in 2012 for a progressive, new
onset exertional angina CCS class III. Selective coronary
angiography was performed via the right femoral artery,
which revealed a signiﬁcant involvement of the native vessels
(signiﬁcant stenosis of the distal LM trunk, tight stenosis of the
proximal LAD and large Diagonal, chronic occlusion of the LCx)
with patent LIMA to LAD bypass and critical bifurcation
stenosis in the Y-graft to the Diagonal and LCx (Medina 1,1,1)
with TIMI ﬂow grade 1–2 in the Diagonal artery area (Fig. 1).
20 mg of Reopro (Abciximab) was administered intracoronary,
the 6F guiding LCB was inserted and two PT MS guidewires
were introduced into the periphery of both branches.
Predilatation was performed using Apex 2.512 mm/6 atmFig. 1 – Right anterior oblique (RAO 15, Cran 30) projection;
tight bifurcation lesion (Medina 1,1,1) in Y saphenous vein
graft to LCx and Dx.and 3.012 mm/8 atm balloon catheters at the origins of both
SVG branches, which resulted in an improved ﬁlling of the
Diagonal area (TIMI ﬂow grade 3). The Tryton 4.0/3.518 mm
bifurcation stent was implanted at 12 atm with its distal arm
oriented towards the SVG to Diagonal (Fig. 2). The stent struts
were recrossed with a wire from SVG–Diagonal to the LCx,
predilatation was performed using the Quantum 3.512 mm
non-compliant balloon catheter at 10 atm and the Promus
Element 4.020 mm drug eluting stent was implanted in the
SVG–LCx direction. Subsequently, the wire was pulled back to
the SVG–Diagonal, both branches were pre-dilated and ﬁnal
kissing post-dilatation was performed using Apex 3.0 and
3.512 mm balloon catheters at 6 atm with a satisfactory
outcome in the Y-graft bifurcation area, and TIMI ﬂow grade 3
to the periphery of both branches (Figs. 3 and 4).
The patient was discharged the following day in a stabilised
condition with dual anti-platelet therapy (ASA 100 mg+clopi-
dogrel 75 mg) for 12 months, a beta blocker (betaxolol 20 mg)
and statins (atorvastatin 40 mg).
At the 12-month follow-up visit, the patient had no
exertional angina and the MS-CT coronary angiography
showed satisfactory ﬁndings at the site of the bifurcation
stent in the Y-shaped vein graft (Figs. 5 and 6).
Case report 2
A 75-year-old female with terminal renal insufﬁciency, included
in the haemodialysis programme, with a history of MI and
repeated PCI of the native arteries, underwent CABG surgery
(LIMA to LAD, Y saphenous vein graft to the LCx and PDA) and
mitral annuloplasty in 2009. The Y-graft was constructed by
grafting the central anastomosis of the SVG–PDA ‘‘end-to side’’
to the SVG–LCx due to a diffuse atheromatous involvement of
the ascending aorta. In 2010, this patient was admitted for
NSTEMI (troponin I 37 ng/mL) which occurred during the course
of haemodialysis. Echocardiography revealed a mildly reduced
left ventricular systolic function with 40% LVEF. Following initial
conservative stabilisation (LMW heparin, dual anti-platelet
therapy ASA 100 mg+clopidogrel 75 mg and nitrates infusion
therapy), selective coronary angiography was performed via the
Fig. 3 – Right anterior oblique (RAO 15, Caud 30) projection;
final result after implantation of Tryton (4.0/3.5T18 mm)
and DES Promus Element (4.0T20 mm) stents.
Fig. 5 – 12 Month follow-up; MS-CT volume-rendered 3-D
image.
Fig. 6 – 12 Month follow-up; maximum intensity projection.
Patent dedicated bifurcation stent Tryton.
Fig. 4 – Left anterior oblique (LAO 30, Cran 30) projection;
final result after implantation of Tryton (4.0/3.5T18 mm)
and DES Promus Element (4.0T20 mm) stents.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 8 2 – e 3 8 7e384right femoral artery, which revealed a signiﬁcant involvement
of the native coronary arteries (tight stenosis of the LAD, LCx
and Marginal and chronic occlusion of the RCA), with a patent
LIMA to LAD bypass and tight bifurcation stenosis in the Y-graft
to PDA and LCx. (80% stenosis extending centrally to the origin of
the side branch of the SVG to PDA, where 90% stenosis is
present, Medina 1,0,1 (Fig. 7).)
Given the involvement of the vein bypass graft, Reopro
16.4 mg was administered intracoronary, the 6F guiding LCB
was inserted and two PT MS guidewires were used to pass
through the lesions in both saphenous vein grafts to thePDA and LCx. We predilated both lesions using the Apex
3.012 mm balloon catheter at 12 atm. While the distal
lesion at the side branch SVG–PDA origin was successfully
predilated, a signiﬁcant residual stenosis at the proximal
lesion persisted. That is why we decided to treat both
lesions using the Sequent Please 4.015 mm drug eluting
balloon catheter at 6 atm and a short stent implantation
(Liberte 4.08 mm/12 atm) only into the proximal residual
stenosis. The result at the site of bifurcation was satisfac-
tory, with TIMI class 3 ﬂow into the periphery of both
branches (Figs. 8 and 9).
Fig. 7 – Left anterior oblique (LAO 30, Cran 15) projection;
tight bifurcation lesion (Medina 1,0,1) in Y saphenous vein
graft to LCx and PDA; (A)—detailed, distal saphenous vein
grafts and native coronary bed.
Fig. 9 – Right anterior oblique (RAO 30, Caud 15) projection;
final result after DEB Sequent Please (4.0T15 mm) and
Liberte stent (4T8 mm) implantation.
Fig. 10 – 12 Month follow-up; MS-CT volume-rendered 3-D
image.
Fig. 8 – Left anterior oblique (LAO 45, Caud 30) projection;
final result after DEB Sequent Please (4.0T15 mm) and
Liberte stent (4T8 mm) implantation.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 8 2 – e 3 8 7 e385During further course of the treatment, the patient was
stabilised and was discharged home following the planned
haemodialysis. The treatment continued with 12-month dual
anti-platelet therapy (ASA 100 mg+clopidogrel 75 mg), beta
blockers (metoprolol 100 mg) and statins (simvastatin 40 mg).
At the 12-month follow-up visit, the patient had no residual
angina, and she had only mild heart failure symptoms (NYHA
class 2), MS-CT scan was further performed, with persistent
satisfactory ﬁndings at the Y-shaped vein graft bifurcation site
(Figs. 10 and 11).Results
In both cases a satisfying angiographic result was achieved. No
periprocedural complication has been recorded. Despite the
fact that we cannot use a distal protection, ﬁnal TIMI ﬂow 3
was reached.
The patients were followed up during 12 months. During
this follow-up period no major adverse cardiac events (MACE:
cardiac death, myocardial infarction and target vessel revas-
cularisation) have been recorded. Both patients were without
residual angina pectoris and in one case with clinical signs of
Fig. 11 – 12 Month follow-up; maximum intensity
projection. Persistent satisfactory angiographic result.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 8 2 – e 3 8 7e386light heart insufﬁciency of NYHA class II. Persistent satisfying
angiographic results were conﬁrmed on MS-CT coronarogra-
phy with conﬁrmation of patent both Y-graft branches,
without the presence of restenosis in the bifurcation lesions.
Discussion
The use of Y-shaped aorto-coronary saphenous vein grafts
is most commonly driven by efforts to replace the poor
quality (length) of the vein grafts or to minimise manipula-
tion of the atheromatous ascending aorta, thus reducing the
risk of perioperative atheroembolic cerebrovascular acci-
dents. The basic requirements for a satisfactory function of
the Y-graft are its proper construction with an adequate
length of the daughter vein graft and appropriate position of
the central anastomosis on the main graft. Inappropriate
length can lead to a kinking of the daughter or parent grafts
and inappropriately  located central anastomosis may result
in twisting of the parent graft and ﬂattening of the
anastomosis [1].
In general, percutaneous coronary intervention of SVGs
results in higher rates of mortality, periprocedural myocardial
infarction and restenosis when compared to native vessel PCI
[5].
Many strategies have been proposed for the treatment of
bifurcation lesions in the native coronary vessels; however,
due to their low incidence, there has been no data concerning
the treatment of bifurcation lesions in Y saphenous vein graftsin the literature. These communications are limited to
anecdotal case reports only [2–4].
Given the foregoing, we should rely on the therapy of
analogous lesions in the native vessels, while considering the
PCI speciﬁcs of saphenous vein grafts. According to the
consensus of the European Bifurcation Club, provisional T-
stenting is considered the golden standard of treatment for
most bifurcation lesions. However, bifurcation lesions with
involvement of a large SB, which exceeds 5 mm from the
carina, usually primarily require the implantation of two
stents. In this case the Cullote technique brings some
advantages over the crush technique due to signiﬁcantly
lower periprocedural AMI and ISR [6,7].
The Tryton Side Branch Stent (Tryton Medical, USA) used by
us in the ﬁrst case, is a dedicated bifurcation chromium–cobalt
stent consisting of three parts: the distal segment which is a
common stent for implantation in the lateral branches; the
middle or ‘‘thin’’ transitional segment; and the proximal
segment to ﬁt in the main branch. The stent allows simple
performance of the ‘‘reverse Cullote technique’’ [8].
In the real world the use of the Tryton Side Branch stent
was studied in the E-Tryton registry (302 patients) and
Rotterdam-Poznan registry (96 patients with coronary bifur-
cation lesions). Both these registries show that treatment of
bifurcation lesions with a dedicated Tryton stent is safe and
feasible, with good technical and procedural success and very
low major adverse cardiac events at 6-month clinical follow-
up. Procedural success rate was 94% and 6-month MACE/
cardiac death, myocardial infarction and target lesion revas-
cularisation/rate were 6%, 4% and 6% respectively [9,10].
In the second case we used a drug eluting balloon and bare
metal spot stenting to treat so-called not true bifurcation
lesion (Medina 1,0,1). Paclitaxel drug-eluting balloons (DEB)
could provide an attractive alternative to treat bifurcations in
combination with a provisional T-stenting technique in order
to minimise SB restenosis.
In the DEBUIT trial, a randomized 3-arm study (117 patients
with coronary bifurcation lesions), however, treatment with
the 1st generation DIORTM paclitaxel coated balloon+BMS in
the main branch did not lead to a signiﬁcant improvement in
the primary endpoint, the 6-month angiographic late luminal
loss (LLL) or in the secondary end points (6-month binary
restenosis and 12-month major adverse cardiac events)
between DEB+BMS arm versus BMS only arm and DES arm.
The main cause for the unsatisfactory outcome in the DEB arm
was the use of the 1st generation Dior DEB, without
hydrophilic coating, which provides inferior results compared
to the hydrophilic coated DEB, and is no longer used [11].
The Pepcad V trial involving 28 patients with coronary
bifurcational lesions demonstrated the feasibility of angio-
plasty using the SeQuentTM Please balloon in the main and the
side branch of the bifurcation followed by bare metal stent
implantation in the main branch. This treatment resulted in a
100% procedural success (primary end-point), no 30-day major
adverse cardiac events (MACE) and the 9-month angiography
follow-up showed DES-like results in MB and SB (comparable
with LLL in the DES arm of Pepcad IV trial) [12].
The ongoing randomised PEPCAD BIF trial compares the
treatment of the side branch with SeQuentTM Please or
conventional angioplasty.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 8 2 – e 3 8 7 e387We used multi-slice CT coronary angiography to demon-
strate the long-term patency of the implanted stents. Usage
of CT coronarography in the demonstration of in-stent
restenosis was assessed by Sun in his meta-analysis. The
achieved sensitivity and speciﬁcity of 64-slice CT angio-
graphy with the detection of in-stent restenosis were
90% and 91%, respectively. Signiﬁcantly higher diagnostic
success was achieved during the evaluation of stents with
the diameter greater than 3 mm (in comparison with stents
under 2.75 or 2.5 mm) [13]. The success achieved during the
evaluation of patency of venous bypass was still higher.
Weusting in his report has shown up to 100% sensitivity of
64-slice CT angiography in the detection of obstructive
impairment of venous grafts [14].
Conclusion
Percutaneous coronary angioplasty of the bifurcation lesions
in the venous bypass grafts is a rare but complicated
condition. In the therapy of these lesions, we can only rely
on the PCI of analogous lesions in the native vasculature,
considering the speciﬁcs of the interventions in the saphe-
nous vein grafts.
In our two case reports we demonstrated that the use of a
dedicated bifurcation Tryton Side Branch Stent, as well as the
SeQuent Please paclitaxel coated balloon catheter for PCI of the
bifurcation lesions in Y-shaped saphenous vein grafts, is
technically feasible with satisfactory long-term results and
represents our contribution to the debate on this particular
issue.
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